Academy of Thoracic Oncology – Multidisciplinary Update on Diagnostic and Treatment Pathways

The European Society of Thoracic Surgeons (ESTS) is pleased to announce the upcoming ERS–ESTS–ESTRO–ESR Academy of Thoracic Oncology – Multidisciplinary Update on Diagnostic and Treatment Pathways, taking place 21–23 October 2026 in Zurich, Switzerland.

This collaborative educational course will bring together leading specialists in thoracic surgery, respiratory medicine, medical oncology, radiation oncology, radiology, and palliative care to provide a comprehensive, multidisciplinary update on the latest developments in lung cancer diagnosis and treatment.

Event Information

Dates: 21–23 October 2026
Location: Zurich, Switzerland

Meeting Programme: Click here

Registration: Register now

Organised by the European Respiratory Society (ERS) in collaboration with ESTS, the European Society for Radiotherapy and Oncology (ESTRO), and the European Society of Radiology (ESR), the Academy offers participants the opportunity to learn from internationally recognised experts and engage in discussions on current evidence, emerging technologies, and future directions in thoracic oncology.

Course Highlights

The programme covers the entire lung cancer care pathway, including:

• Lung cancer screening and early detection

• Staging and multidisciplinary diagnosis

• Advances in biopsy techniques and biomarker integration

• Personalised treatment strategies

• Surgical, medical and radiation oncology approaches

• Outcome prediction and clinical decision-making

• Palliative care and complex resuscitation ethics

Participants will gain practical, evidence-based knowledge that can be directly applied to multidisciplinary clinical practice.

Who Should Attend?

The course is designed for healthcare professionals with an interest in thoracic oncology, including:

• Thoracic surgeons

• Respiratory physicians

• Medical oncologists

• Radiation oncologists

• Radiologists

• Palliative care physicians

• Clinical nurse specialists

• Early career clinicians interested in thoracic oncology

Learning Objectives

By the end of the course, participants will be able to:

• Evaluate the current landscape of thoracic oncology diagnostics across different healthcare settings.

• Assess emerging technologies and their potential impact on future clinical practice.

• Critically review the factors influencing multidisciplinary treatment decision-making.

• Design personalised lung cancer treatment strategies to optimise patient outcomes.

We encourage all ESTS members and healthcare professionals involved in thoracic oncology to take advantage of this unique multidisciplinary educational opportunity and join colleagues from across Europe for three days of expert-led learning, collaboration, and professional development.

---

View other News Articles